Abstract
In the presence of normal CXR and examination perhaps FEV1 is a better diagnostic marker of COPD in primary care http://bit.ly/2QAUpSA
Footnotes
Conflict of interest: G. Hamad reports institutional grants from AstraZeneca during the conduct of the study.
Conflict of interest: A. Rigby has nothing to disclose.
Conflict of interest: A.H. Morice reports grants from AstraZeneca, during the conduct of the study.
- Received November 4, 2019.
- Accepted November 15, 2019.
- Copyright ©ERS 2020
INDIVIDUALS
Log in using your username and password
LIBRARY USERS
Log in through your institution
If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
CONTACT US
If you have any questions about the ERS publications website, please contact journals@ersnet.org
Vol 55 Issue 1
Table of Contents
Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry
